Organovo implements 1-for-12 reverse stock split to regain Nasdaq minimum bid price compliance

VivoSim Labs, INC.

Reverse stock split at ratio 1-for-12, effective March 20, 2025, to combine every 12 shares into 1.
Trading on Nasdaq Capital Market on split-adjusted basis begins March 21, 2025 under ticker ONVO.
No fractional shares issued; cash paid in lieu based on March 19 closing price of common stock.
Board approved reverse split ratio on March 6, 2025 after shareholder authorization granted November 20, 2024.
Reverse split intended to cure Nasdaq minimum bid price deficiency for continued listing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

VivoSim Labs, INC.: On March 20, 2025, the company filed a Certificate of Third Amendment to its Certificate of Incorporation to effect a 1-for-12 reverse stock split (effective 2025-03-20).

Change: charter amendment
Effective: 2025-03-20

Exact text from the filing

On March 20, 2025, Organovo Holdings, Inc. (the “Company”) filed a Certificate of Third Amendment to its Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware to effect a 1-for-12 reverse stock split (the “Reverse Split”) of the shares of Company’s common stock, par value $0.001 per share (“Common Stock”).

View on SEC.gov

Browse all governance changes →

VivoSim Labs, INC. filing history →

Source: SEC EDGAR

accession 0000950170-25-042903

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.